Pharmacogenetics of the Metabolic Disturbances and Atherosclerosis Associated with Antiretroviral Therapy in HIV-Infected Patients

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|16|30|3379-3389

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.30, 2010-10, pp. : 3379-3389

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nephrotoxicity associated with antiretroviral therapy in HIV-infected patients

By Harris Marianne  

Expert Opinion on Drug Safety, Vol. 7, Iss. 4, 2008-07 ,pp. : 389-400

Informa Healthcare

Access to resources Recommend Favorite

Cardiovascular risk associated with antiretroviral therapy in HIV-infected patients

By Calza Dr Leonardo   Manfredi Roberto   Chiodo Francesco  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 11, 2006-11 ,pp. : 1497-1516

Informa Healthcare

Access to resources Recommend Favorite

Metabolic complications of antiretroviral therapy in HIV-infected children

By Eley Brian  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 1, 2008-01 ,pp. : 37-49

Informa Healthcare

Access to resources Recommend Favorite

Highly Active Antiretroviral Therapy and Cardiovascular Complications in HIV-Infected Patients

By  

Current Pharmaceutical Design, Vol. 9, Iss. 18, 2003-07 ,pp. : 1475-1481

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of Antiretroviral Therapy on Immunity in Patients Infected with HIV

By  

Current Pharmaceutical Design, Vol. 12, Iss. 9, 2006-03 ,pp. : 1015-1022

Bentham Science Publishers

Access to resources Recommend Favorite